Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, has received a U.S. Food and Drug Administration (FDA) 510(k) approval for its Proximal Tibia Plating System.
Tyber Medical LLC, a leading orthopedic device manufacturer providing private label orthopedic implants for the trauma, extremity, and spine markets, received clearance for the anatomical plating system in Canada. The comprehensive portfolio previously received FDA 510(k) in the US and has now been cleared through Health Canada.
Dermatologist-recommended skincare brand La Roche-Posay celebrates its third annual National Hyaluronic Acid Day on January 21st. The brand created this day to inform consumers of the many hydrating and anti-aging benefits of hyaluronic acid and educate on proper usage.
Stryker one of the world’s leading medical technologies companies, has expanded its Gamma4 Hip Fracture Nailing System, with the addition of an intermediate nail, the RC Lag Screw, and an anti-rotation clip with sleeve components.
Westchester Medical Center, the flagship academic medical center for the Westchester Medical Center Health Network (WMCHealth), is set to become the first hospital in New York State to introduce the non-invasive surgical robotics platform, the ZAP-X® Gyroscopic Radiosurgery®,
In keeping with its mission to embrace innovation and leverage cutting-edge technology, Postal Center International® (PCI®) has made a strategic investment in not one but two new state-of-the-art BlueCrest Vantage Mixed Thickness and Mixed Weight Flat Sorters — the first ones in the United States running on the NetSort platform.
In a landmark collaboration, Sodexo, a global leader in quality-of-life services, is expanding its partnership with Bear Robotics, the Silicon Valley innovator behind indoor self-driving service robots. Together, they are reshaping healthcare services, ushering in a new era of patient and staff support and care that will establish an industry benchmark for excellence.
GE HealthCare’s Artificial Intelligence (AI) models predict patient response to immunotherapies with 70 to 80 percent accuracy1, based on a pan-cancer cohort, according to findings to be presented at the Society for Immunotherapy of Cancer (SITC) in San Diego, U.S., by GE HealthCare, Vanderbilt University Medical Center (VUMC) and the University Medicine Essen (UME), Germany.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced initial findings from the multicenter observational study Assessing Brain Injury Using Portable Magnetic Resonance Imaging in Patients With Extracorporeal Membrane Oxygenation.
ChromaDex Corp. (NASDAQ:CDXC), a global authority on Nicotinamide Adenine Dinucleotide (NAD+) research and healthy aging, launches its clinical strength Tru Niagen® Pro 1,000mg, featuring 1,000mg of Niagen® (patented Nicotinamide Riboside or NR), one of the most efficient and superior quality NAD+ precursors on the market, to consumers nationwide.